$CGC
Canopy Growth Corp

2023 Q1 Form 10-Q Financial Statement

#000095017023002383 Filed on February 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4
Revenue $73.71M $101.2M
YoY Change -34.05% -28.2%
Cost Of Revenue $177.8M $103.7M
YoY Change -34.38% -20.8%
Gross Profit -$104.1M -$2.441M
YoY Change -34.61% -124.19%
Gross Profit Margin -141.26% -2.41%
Selling, General & Admin $104.8M $122.6M
YoY Change -5.03% 4.97%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $20.77M $20.60M
YoY Change -31.87% -31.37%
% of Gross Profit
Operating Expenses $113.8M $151.3M
YoY Change -11.96% 29.52%
Operating Profit -$217.9M -$153.8M
YoY Change -24.46% 2.54%
Interest Expense -$64.28M $33.29M
YoY Change 18.27% 26.05%
% of Operating Profit
Other Income/Expense, Net $12.47M -$113.3M
YoY Change 238.63% -430.61%
Pretax Income -$739.7M -$267.1M
YoY Change 26.0% 130.9%
Income Tax -$16.36M -$382.0K
% Of Pretax Income
Net Earnings -$711.6M -$261.6M
YoY Change 23.84% 140.15%
Net Earnings / Revenue -965.39% -258.45%
Basic Earnings Per Share -$0.54
Diluted Earnings Per Share -$1.44 -$0.54
COMMON SHARES
Basic Shares Outstanding 494.9M 485.9M
Diluted Shares Outstanding 486.1M

Balance Sheet

Concept 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $782.6M $789.3M
YoY Change -42.94% -44.54%
Cash & Equivalents $677.0M $598.1M
Short-Term Investments $105.6M $191.1M
Other Short-Term Assets $10.12M $14.89M
YoY Change -46.94% -84.88%
Inventory $148.9M $213.9M
Prepaid Expenses $27.46M $28.74M
Receivables $66.82M $85.30M
Other Receivables $11.66M $8.923M
Total Short-Term Assets $1.077B $1.173B
YoY Change -38.0% -41.01%
LONG-TERM ASSETS
Property, Plant & Equipment $499.5M $874.0M
YoY Change -47.02% -19.08%
Goodwill $85.56M $142.1M
YoY Change -95.42% -92.85%
Intangibles $188.7M $213.5M
YoY Change -25.32% -36.97%
Long-Term Investments $568.3M $598.4M
YoY Change -28.99% -33.4%
Other Assets $19.80M $19.22M
YoY Change 29.08% 26.51%
Total Long-Term Assets $1.362B $1.847B
YoY Change -64.88% -57.25%
TOTAL ASSETS
Total Short-Term Assets $1.077B $1.173B
Total Long-Term Assets $1.362B $1.847B
Total Assets $2.439B $3.020B
YoY Change -56.56% -52.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $76.23M $63.14M
YoY Change 18.62% -6.93%
Accrued Expenses $85.13M $75.99M
YoY Change -2.18% -0.03%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $556.9M $455.5M
YoY Change 5890.64% 2800.8%
Total Short-Term Liabilities $803.8M $678.7M
YoY Change 277.57% 183.7%
LONG-TERM LIABILITIES
Long-Term Debt $750.0M $750.1M
YoY Change -49.72% -49.81%
Other Long-Term Liabilities $124.9M $141.9M
YoY Change -34.29% -27.47%
Total Long-Term Liabilities $874.9M $892.0M
YoY Change -47.98% -47.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $803.8M $678.7M
Total Long-Term Liabilities $874.9M $892.0M
Total Liabilities $1.679B $1.580B
YoY Change -15.23% -24.65%
SHAREHOLDERS EQUITY
Retained Earnings -$9.673B -$8.938B
YoY Change 51.84%
Common Stock $10.45B $10.38B
YoY Change 4.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $758.4M $1.426B
YoY Change
Total Liabilities & Shareholders Equity $2.439B $3.020B
YoY Change -56.56% -52.13%

Cashflow Statement

Concept 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$711.6M -$261.6M
YoY Change 23.84% 140.15%
Depreciation, Depletion And Amortization $20.77M $20.60M
YoY Change -31.87% -31.37%
Cash From Operating Activities -$139.7M -$143.9M
YoY Change 10.3% -14.03%
INVESTING ACTIVITIES
Capital Expenditures $3.113M $2.195M
YoY Change -144.93% -178.48%
Acquisitions
YoY Change
Other Investing Activities $94.37M $137.3M
YoY Change -69.45% -723.95%
Cash From Investing Activities $91.25M $135.1M
YoY Change -69.78% -644.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 126.2M -133.5M
YoY Change 15580.37% -39023.62%
NET CHANGE
Cash From Operating Activities -139.7M -143.9M
Cash From Investing Activities 91.25M 135.1M
Cash From Financing Activities 126.2M -133.5M
Net Change In Cash 77.74M -142.3M
YoY Change -55.84% -25.84%
FREE CASH FLOW
Cash From Operating Activities -$139.7M -$143.9M
Capital Expenditures $3.113M $2.195M
Free Cash Flow -$142.9M -$146.1M
YoY Change 19.28% -11.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Trading Symbol
TradingSymbol
CGC
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q1 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
cgc Number Of Whole Warrants On Expiry Of Warrants
NumberOfWholeWarrantsOnExpiryOfWarrants
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
dei Entity Central Index Key
EntityCentralIndexKey
0001737927
CY2022Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
cgc Average Exercise Price On Warrant Expiry
AverageExercisePriceOnWarrantExpiry
cgc Warrant Value Expiry Of Warrants
WarrantValueExpiryOfWarrants
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38496
dei Entity Registrant Name
EntityRegistrantName
Canopy Growth Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
Z4
dei Entity Address Address Line1
EntityAddressAddressLine1
1 Hershey Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Smiths Falls
dei Entity Address State Or Province
EntityAddressStateOrProvince
ON
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
K7A 0A8
dei City Area Code
CityAreaCode
855
dei Local Phone Number
LocalPhoneNumber
558-9333
dei Security12b Title
Security12bTitle
Common shares, no par value
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
160051000
us-gaap Operating Expenses
OperatingExpenses
2167828000
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
494894047
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
598131000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
776005000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
191119000
CY2022Q1 us-gaap Short Term Investments
ShortTermInvestments
595651000
CY2022Q4 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
12932000
CY2022Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
96443000
CY2022Q1 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
12216000
CY2022Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
104640000
CY2022Q4 us-gaap Inventory Net
InventoryNet
213937000
CY2022Q1 us-gaap Inventory Net
InventoryNet
204387000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
52151000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
52700000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1172910000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
1737402000
CY2022Q4 cgc Other Financial Assets
OtherFinancialAssets
598387000
CY2022Q1 cgc Other Financial Assets
OtherFinancialAssets
800328000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
874029000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
942780000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
213530000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
252695000
CY2022Q4 us-gaap Goodwill
Goodwill
142076000
CY2022Q1 us-gaap Goodwill
Goodwill
1866503000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
19223000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
15342000
CY2022Q4 us-gaap Assets
Assets
3020155000
CY2022Q1 us-gaap Assets
Assets
5615050000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
63139000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
64270000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
75985000
CY2022Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
75278000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
455483000
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
9296000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
84134000
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
64054000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
678741000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
212898000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
750118000
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1491695000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
8988000
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15991000
CY2022Q1 cgc Liability Arising From Acreage Arrangement
LiabilityArisingFromAcreageArrangement
47000000
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
668000
CY2022Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
26920000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
141891000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
190049000
CY2022Q4 us-gaap Liabilities
Liabilities
1580406000
CY2022Q1 us-gaap Liabilities
Liabilities
1984553000
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
11408000
CY2022Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
36200000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
494891390
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
394422604
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
7867310000
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
7482809000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2510086000
us-gaap Operating Expenses
OperatingExpenses
519219000
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-153764000
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-149961000
us-gaap Operating Income Loss
OperatingIncomeLoss
-2167840000
us-gaap Operating Income Loss
OperatingIncomeLoss
-553031000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-100000
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-113340000
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2519766000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14248000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-42282000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8937603000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6370337000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1425545000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3589956000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
2796000
CY2022Q1 us-gaap Minority Interest
MinorityInterest
4341000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1428341000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3594297000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3020155000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5615050000
CY2022Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
113349000
CY2021Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
155024000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
366570000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
456095000
CY2022Q4 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
12136000
CY2021Q4 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
14052000
us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
37379000
us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
47540000
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
101213000
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
140972000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
329191000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
408555000
CY2022Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
103654000
CY2021Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
130882000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
329203000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
442367000
CY2022Q4 us-gaap Gross Profit
GrossProfit
-2441000
CY2021Q4 us-gaap Gross Profit
GrossProfit
10090000
us-gaap Gross Profit
GrossProfit
-12000
us-gaap Gross Profit
GrossProfit
-33812000
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
122636000
CY2021Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
116835000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
351891000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
355165000
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
6428000
CY2021Q4 us-gaap Share Based Compensation
ShareBasedCompensation
6777000
us-gaap Share Based Compensation
ShareBasedCompensation
21725000
us-gaap Share Based Compensation
ShareBasedCompensation
35856000
CY2022Q4 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
22259000
CY2021Q4 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
36439000
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
1794212000
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
128198000
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
151323000
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
34282000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-406762000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
810769000
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-382000
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-183000
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-267104000
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-115679000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11587000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2574602000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
257638000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-490000
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-266722000
CY2021Q4 us-gaap Profit Loss
ProfitLoss
-115496000
us-gaap Profit Loss
ProfitLoss
-2586189000
us-gaap Profit Loss
ProfitLoss
258128000
CY2022Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-5139000
CY2021Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-6571000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-19652000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-14307000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-261583000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-108925000
us-gaap Net Income Loss
NetIncomeLoss
-2566537000
us-gaap Net Income Loss
NetIncomeLoss
272435000
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.70
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
486112598
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
393818282
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
453237882
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
390423083
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.66
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
486112598
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
393818282
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
453237882
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
410986802
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-266722000
CY2021Q4 us-gaap Profit Loss
ProfitLoss
-115496000
us-gaap Profit Loss
ProfitLoss
-2586189000
us-gaap Profit Loss
ProfitLoss
258128000
CY2022Q4 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent
4538000
CY2021Q4 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent
16200000
us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent
32847000
us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent
26280000
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
14921000
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-15479000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
24694000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-18767000
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
19459000
CY2021Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
721000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
57541000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7513000
CY2022Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-247263000
CY2021Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-114775000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2528648000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
265641000
CY2021Q4 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-6571000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-19652000
CY2022Q4 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-5139000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-14307000
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-242124000
CY2021Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-108204000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2508996000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
279948000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3594297000
cgc Adjustments To Additional Paid In Capital Other Issuances Of Common Shares And Warrants Value
AdjustmentsToAdditionalPaidInCapitalOtherIssuancesOfCommonSharesAndWarrantsValue
80499000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
270000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20892000
us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
-24791000
us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
1851000
cgc Stock Issued During Period Value Redemption Of Redeemable Noncontrolling Interest
StockIssuedDuringPeriodValueRedemptionOfRedeemableNoncontrollingInterest
-5092000
cgc Stock Issued During Period Value Settlement Of Unsecured Senior Notes
StockIssuedDuringPeriodValueSettlementOfUnsecuredSeniorNotes
235758000
cgc Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2528648000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1428341000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3486520000
cgc Adjustments To Additional Paid In Capital Other Issuances Of Common Shares And Warrants Value
AdjustmentsToAdditionalPaidInCapitalOtherIssuancesOfCommonSharesAndWarrantsValue
266448000
cgc Replacement Equity Instruments
ReplacementEquityInstruments
18916000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5455000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
35172000
us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
66600000
us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
684000
cgc Stock Issued During Period Value Redemption Of Redeemable Noncontrolling Interest
StockIssuedDuringPeriodValueRedemptionOfRedeemableNoncontrollingInterest
-2492000
cgc Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
265641000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4142944000
us-gaap Profit Loss
ProfitLoss
-2586189000
us-gaap Profit Loss
ProfitLoss
258128000
us-gaap Depreciation
Depreciation
43185000
us-gaap Depreciation
Depreciation
56467000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
20561000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
27462000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-100000
cgc Share Based Compensation Including Amounts Recorded In Selling General And Administrative Expenses
ShareBasedCompensationIncludingAmountsRecordedInSellingGeneralAndAdministrativeExpenses
21725000
cgc Share Based Compensation Including Amounts Recorded In Selling General And Administrative Expenses
ShareBasedCompensationIncludingAmountsRecordedInSellingGeneralAndAdministrativeExpenses
35856000
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
1797854000
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
113250000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11587000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-490000
cgc Non Cash Fair Value Adjustments And Charges Related To Settlement Of Unsecured Senior Notes
NonCashFairValueAdjustmentsAndChargesRelatedToSettlementOfUnsecuredSeniorNotes
325742000
cgc Non Cash Fair Value Adjustments And Charges Related To Settlement Of Unsecured Senior Notes
NonCashFairValueAdjustmentsAndChargesRelatedToSettlementOfUnsecuredSeniorNotes
-893024000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8197000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4083000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9550000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-6702000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6866000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-28818000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3202000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-30764000
cgc Increase Decrease In Other Non Cash Foreign Currency
IncreaseDecreaseInOtherNonCashForeignCurrency
24459000
cgc Increase Decrease In Other Non Cash Foreign Currency
IncreaseDecreaseInOtherNonCashForeignCurrency
25713000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
4564000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-417809000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-419125000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6176000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36620000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1265000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
10894000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
25660000
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-415322000
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-340218000
us-gaap Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates
ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
12432000
us-gaap Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates
ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
10324000
cgc Payments For Proceeds From Other Financial Assets
PaymentsForProceedsFromOtherFinancialAssets
67186000
cgc Payments For Proceeds From Other Financial Assets
PaymentsForProceedsFromOtherFinancialAssets
374414000
cgc Payments To Acquire Subsidiaries
PaymentsToAcquireSubsidiaries
24223000
cgc Payments To Acquire Subsidiaries
PaymentsToAcquireSubsidiaries
14947000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-2327000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
16759000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
342125000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-71102000
cgc Proceeds From Issuance Of Common Shares And Warrants
ProceedsFromIssuanceOfCommonSharesAndWarrants
856000
cgc Proceeds From Issuance Of Common Shares And Warrants
ProceedsFromIssuanceOfCommonSharesAndWarrants
1460000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
270000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5455000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
117951000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
50217000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-29096000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-3036000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-145921000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-46338000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43731000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2942000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-177874000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-539507000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
776005000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1154653000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
598131000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
615146000
cgc Income Taxes Received
IncomeTaxesReceived
4709000
cgc Income Taxes Received
IncomeTaxesReceived
993000
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
20140000
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
10844000
us-gaap Income Taxes Paid
IncomeTaxesPaid
1099000
us-gaap Income Taxes Paid
IncomeTaxesPaid
2641000
us-gaap Interest Paid Net
InterestPaidNet
95267000
us-gaap Interest Paid Net
InterestPaidNet
83968000
cgc Increase Decrease Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseCapitalExpendituresIncurredButNotYetPaid
-425000
cgc Increase Decrease Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseCapitalExpendituresIncurredButNotYetPaid
5145000
CY2022Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
2311000
CY2022Q4 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
22259000
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
1794212000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:4.52%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of estimates</span></p><p style="text-indent:4.52%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of these condensed interim consolidated financial statements and accompanying notes in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ from those estimates.</span></p>
CY2022Q4 us-gaap Warrants And Rights Outstanding Maturity Date
WarrantsAndRightsOutstandingMaturityDate
2032-12-31
CY2022Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
2000000
CY2022Q4 cgc Percentage Ownership Of Wholly Owned Subsidiaries
PercentageOwnershipOfWhollyOwnedSubsidiaries
1
CY2022Q4 cgc Minimum Percentage Of Votes Cast For Approval Of Amendment Proposal
MinimumPercentageOfVotesCastForApprovalOfAmendmentProposal
0.66
CY2022Q4 cgc Debt Instrument Discounted Price
DebtInstrumentDiscountedPrice
930000
us-gaap Deconsolidation Nature Of Continuing Involvement Description
DeconsolidationNatureOfContinuingInvolvementDescription
Company is prepared to make changes to the structure of its interest in Canopy USA such that Canopy Growth would not be required to consolidate the financial results of Canopy USA into Canopy Growth’s financial statements, which may include: (1) reducing Canopy Growth’s economic interest in Canopy USA on an as-converted basis to no greater than 90%; (2) reducing the number of managers on Canopy USA’s board of managers from four to three, including, reducing Canopy Growth’s nomination right to a single manager; (3) modifying the terms of the Protection Agreement and Canopy USA’s Limited Liability Company Agreement in order to eliminate certain negative covenants; and (4) modifying the terms of the agreements with third-party investors in Canopy USA to, among other things, eliminate their right to guaranteed returns
CY2021Q4 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
36439000
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
128198000
CY2022Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
599862000
CY2022Q4 us-gaap Cash
Cash
524979000
CY2022Q1 us-gaap Cash
Cash
470682000
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
73152000
CY2022Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
305323000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
598131000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
776005000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
191119000
CY2022Q1 us-gaap Short Term Investments
ShortTermInvestments
595651000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
193537000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
85297000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
78059000
CY2022Q4 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
7835000
CY2022Q1 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
7524000
CY2022Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
2585000
CY2022Q1 us-gaap Interest Receivable Current
InterestReceivableCurrent
4406000
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
8923000
CY2022Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
6454000
CY2022Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
104640000
CY2022Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
96443000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6477000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4764000
CY2022Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
34940000
CY2022Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
26821000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
64483000
CY2022Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
65245000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
114514000
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
112321000
CY2022Q4 us-gaap Inventory Net
InventoryNet
213937000
CY2022Q1 us-gaap Inventory Net
InventoryNet
204387000
CY2022Q4 us-gaap Inventory Write Down
InventoryWriteDown
9820000
us-gaap Inventory Write Down
InventoryWriteDown
32978000
CY2021Q4 us-gaap Inventory Write Down
InventoryWriteDown
11811000
us-gaap Inventory Write Down
InventoryWriteDown
104662000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
28736000
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
23041000
CY2022Q4 cgc Prepaid Deposits Current
PrepaidDepositsCurrent
7740000
CY2022Q1 cgc Prepaid Deposits Current
PrepaidDepositsCurrent
10145000
CY2022Q4 cgc Prepaid Inventory Current
PrepaidInventoryCurrent
786000
CY2022Q1 cgc Prepaid Inventory Current
PrepaidInventoryCurrent
449000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
14889000
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
19065000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
52151000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
52700000
CY2022Q1 cgc Other Noncurrent Financial Asset
OtherNoncurrentFinancialAsset
800328000
cgc Other Financial Assets Additions
OtherFinancialAssetsAdditions
253659000
cgc Changes In Other Financial Asset Fair Value Through Profit Or Loss
ChangesInOtherFinancialAssetFairValueThroughProfitOrLoss
-396755000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
31961000
cgc Other Financial Assets Other
OtherFinancialAssetsOther
90806000
CY2022Q4 cgc Other Noncurrent Financial Asset
OtherNoncurrentFinancialAsset
598387000
CY2022Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
89094000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1064085000
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1175692000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
190056000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
232912000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
874029000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
942780000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
281613000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
150756000
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
276057000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
167886000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
213530000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
252695000
CY2021Q1 us-gaap Goodwill
Goodwill
1889354000
CY2022 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
105323000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
40748000
CY2022 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-28640000
CY2022Q1 us-gaap Goodwill
Goodwill
1866503000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1727679000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
3479000
CY2022Q4 us-gaap Goodwill
Goodwill
142076000
CY2022Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
2311000
CY2022Q4 us-gaap Goodwill
Goodwill
142076000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
29213000
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
24873000
CY2022Q4 us-gaap Inventory Adjustments
InventoryAdjustments
951000
CY2022Q1 us-gaap Inventory Adjustments
InventoryAdjustments
10096000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
6891000
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
7640000
CY2022Q4 cgc Taxes And Government Fees Payable Current
TaxesAndGovernmentFeesPayableCurrent
8541000
CY2022Q1 cgc Taxes And Government Fees Payable Current
TaxesAndGovernmentFeesPayableCurrent
7144000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
30389000
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
25525000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
75985000
CY2022Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
75278000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
325555000
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
563958000
CY2022Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
2266000
CY2022Q1 us-gaap Other Long Term Debt
OtherLongTermDebt
2808000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
455483000
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
9296000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
750118000
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1491695000
CY2021Q1 cgc Debt Instrument Discounted Price
DebtInstrumentDiscountedPrice
930000
CY2021Q1 cgc Liquidity Requirement
LiquidityRequirement
200000000
CY2022Q4 cgc Reduced Liquidity Requirement
ReducedLiquidityRequirement
100000000
CY2021Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
893160000
cgc Debt Instrument Fair Value Of Common Shares
DebtInstrumentFairValueOfCommonShares
76424000
CY2022Q3 cgc Debt Instrument Final Closing Trading Days
DebtInstrumentFinalClosingTradingDays
P10D
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
39896000
CY2020Q3 cgc Accretion Rate
AccretionRate
0.1106
CY2020Q3 cgc Conversion Of Outstanding Debentures Description
ConversionOfOutstandingDebenturesDescription
In addition, the Company may force conversion of the Supreme Debentures outstanding with 30 days’ notice if the daily volume weighted average trading price of the Company’s common shares is greater than $38.59 for any 10 consecutive trading days. The Company, Supreme Cannabis and the Trustee entered into a further supplemental indenture whereby the Company agreed to guarantee the obligations of Supreme Cannabis pursuant to the Supreme Debentures and the Accretion Debentures.
CY2022Q4 cgc Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
35537000
CY2022Q4 cgc Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
83167000
CY2022Q4 cgc Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
118704000
CY2022Q1 cgc Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
38035000
CY2022Q1 cgc Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
101125000
CY2022Q1 cgc Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
139160000
CY2022Q4 cgc Acquisition Consideration Related Liabilities Current
AcquisitionConsiderationRelatedLiabilitiesCurrent
7908000
CY2022Q4 cgc Acquisition Consideration Related Liabilities Noncurrent
AcquisitionConsiderationRelatedLiabilitiesNoncurrent
47169000
CY2022Q4 cgc Acquisition Consideration Related Liabilities
AcquisitionConsiderationRelatedLiabilities
55077000
CY2022Q1 cgc Acquisition Consideration Related Liabilities Current
AcquisitionConsiderationRelatedLiabilitiesCurrent
4020000
CY2022Q1 cgc Acquisition Consideration Related Liabilities Noncurrent
AcquisitionConsiderationRelatedLiabilitiesNoncurrent
77834000
CY2022Q1 cgc Acquisition Consideration Related Liabilities
AcquisitionConsiderationRelatedLiabilities
81854000
CY2022Q4 cgc Refund Liability Current
RefundLiabilityCurrent
2937000
CY2022Q4 cgc Refund Liability
RefundLiability
2937000
CY2022Q1 cgc Refund Liability Current
RefundLiabilityCurrent
3437000
CY2022Q1 cgc Refund Liability
RefundLiability
3437000
CY2022Q4 cgc Settlement Liabilities And Other Current
SettlementLiabilitiesAndOtherCurrent
37752000
CY2022Q4 cgc Settlement Liabilities And Other Non Current
SettlementLiabilitiesAndOtherNonCurrent
11555000
CY2022Q4 cgc Settlement Liabilities And Other
SettlementLiabilitiesAndOther
49307000
CY2022Q1 cgc Settlement Liabilities And Other Current
SettlementLiabilitiesAndOtherCurrent
18562000
CY2022Q1 cgc Settlement Liabilities And Other Non Current
SettlementLiabilitiesAndOtherNonCurrent
11090000
CY2022Q1 cgc Settlement Liabilities And Other
SettlementLiabilitiesAndOther
29652000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
84134000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
141891000
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
226025000
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
64054000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
190049000
CY2022Q1 us-gaap Other Liabilities
OtherLiabilities
254103000
CY2022Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
36200000
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
-17808000
cgc Redeemable Noncontrolling Interest Change In Redemption Value
RedeemableNoncontrollingInterestChangeInRedemptionValue
20366000
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
11408000
cgc Number Of Shares Issued Relating To Completion Of Acquisition Milestones
NumberOfSharesIssuedRelatingToCompletionOfAcquisitionMilestones
222421
CY2021Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
135300000
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
-13100000
CY2022Q4 cgc Number Of Equity Financing
NumberOfEquityFinancing
0
CY2021Q4 cgc Number Of Equity Financing
NumberOfEquityFinancing
0
cgc Business Acquisition Share Based Compensation Reserve
BusinessAcquisitionShareBasedCompensationReserve
-1732000
cgc Redeemable Noncontrolling Interest Change In Redemption Value
RedeemableNoncontrollingInterestChangeInRedemptionValue
-48391000
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
68700000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y2M8D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
27.07
cgc Number Of Shares Issued Relating To Completion Of Acquisition Milestones
NumberOfSharesIssuedRelatingToCompletionOfAcquisitionMilestones
1295285
CY2022Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
128193047
CY2022Q1 cgc Warrants Average Exercise Price
WarrantsAverageExercisePrice
58.04
CY2022Q1 cgc Warrant Value
WarrantValue
2581788000
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
128193047
CY2022Q4 cgc Warrants Average Exercise Price
WarrantsAverageExercisePrice
58.04
CY2022Q4 cgc Warrant Value
WarrantValue
2581788000
CY2021Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
127073136
CY2021Q1 cgc Warrants Average Exercise Price
WarrantsAverageExercisePrice
58.33
CY2021Q1 cgc Warrant Value
WarrantValue
2568438000
cgc Number Of Supreme Cannabis Warrants
NumberOfSupremeCannabisWarrants
1265742
cgc Average Of Supreme Cannabis Warrants
AverageOfSupremeCannabisWarrants
25.61
cgc Warrant Value Supreme Cannabis Warrants
WarrantValueSupremeCannabisWarrants
13350000
cgc Number Of Whole Warrants On Expiry Of Warrants
NumberOfWholeWarrantsOnExpiryOfWarrants
145831
cgc Average Exercise Price On Warrant Expiry
AverageExercisePriceOnWarrantExpiry
32.61
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
128193047
CY2021Q4 cgc Warrants Average Exercise Price
WarrantsAverageExercisePrice
58.04
CY2021Q4 cgc Warrant Value
WarrantValue
2581788000
CY2020Q3 cgc Extended Period Of Option From Grant Date
ExtendedPeriodOfOptionFromGrantDate
P10Y
CY2020Q3 cgc Maximum Period Of Option From Grant Date
MaximumPeriodOfOptionFromGrantDate
P6Y
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
16782962
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
33.89
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4651176
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.94
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
76929
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.41
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
6058172
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
29.37
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
15299037
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
27.07
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
15299037
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y3M7D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
9330692
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
37.46
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
33.89
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
38.33
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0347
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0121
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.82
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.75
CY2022Q4 cgc Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0.20
CY2021Q4 cgc Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0.18
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.34
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.55
CY2021Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
971000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4376000
CY2022Q4 cgc Number Of Common Shares Issued Relating To Completion Of Acquisition Milestones
NumberOfCommonSharesIssuedRelatingToCompletionOfAcquisitionMilestones
222421
cgc Number Of Common Shares Issued Relating To Completion Of Acquisition Milestones
NumberOfCommonSharesIssuedRelatingToCompletionOfAcquisitionMilestones
222421
CY2021Q4 cgc Number Of Common Shares Issued Relating To Completion Of Acquisition Milestones
NumberOfCommonSharesIssuedRelatingToCompletionOfAcquisitionMilestones
419884
cgc Number Of Common Shares Issued Relating To Completion Of Acquisition Milestones
NumberOfCommonSharesIssuedRelatingToCompletionOfAcquisitionMilestones
1295285
cgc Share Based Compensation Number Of Shares To Be Issued On Completion Of Acquisition And Asset Purchase Milestones
ShareBasedCompensationNumberOfSharesToBeIssuedOnCompletionOfAcquisitionAndAssetPurchaseMilestones
125489
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
101213000
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
140972000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
329191000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
408555000
CY2022Q4 cgc Allowance For Estimated Returns And Price Adjustments
AllowanceForEstimatedReturnsAndPriceAdjustments
8869000
cgc Allowance For Estimated Returns And Price Adjustments
AllowanceForEstimatedReturnsAndPriceAdjustments
15345000
CY2021Q4 cgc Allowance For Estimated Returns And Price Adjustments
AllowanceForEstimatedReturnsAndPriceAdjustments
3726000
cgc Allowance For Estimated Returns And Price Adjustments
AllowanceForEstimatedReturnsAndPriceAdjustments
12375000
CY2022Q4 cgc Liability For Estimated Sales Returns And Price Adjustments
LiabilityForEstimatedSalesReturnsAndPriceAdjustments
2937000
CY2022Q1 cgc Liability For Estimated Sales Returns And Price Adjustments
LiabilityForEstimatedSalesReturnsAndPriceAdjustments
3437000
CY2022Q4 cgc Other Financial Assets Fair Value Adjustment
OtherFinancialAssetsFairValueAdjustment
95815000
CY2021Q4 cgc Other Financial Assets Fair Value Adjustment
OtherFinancialAssetsFairValueAdjustment
68666000
cgc Other Financial Assets Fair Value Adjustment
OtherFinancialAssetsFairValueAdjustment
396755000
cgc Acreage Arrangement Liability Fair Value Adjustment
AcreageArrangementLiabilityFairValueAdjustment
47000000
cgc Acreage Arrangement Liability Fair Value Adjustment
AcreageArrangementLiabilityFairValueAdjustment
497000000
CY2022Q4 cgc Unsecured Notes Fair Value Adjustment
UnsecuredNotesFairValueAdjustment
-8964000
CY2021Q4 cgc Unsecured Notes Fair Value Adjustment
UnsecuredNotesFairValueAdjustment
606000
cgc Other Financial Assets Fair Value Adjustment
OtherFinancialAssetsFairValueAdjustment
263946000
CY2021Q4 cgc Acreage Arrangement Liability Fair Value Adjustment
AcreageArrangementLiabilityFairValueAdjustment
59000000
cgc Unsecured Notes Fair Value Adjustment
UnsecuredNotesFairValueAdjustment
-32365000
cgc Unsecured Notes Fair Value Adjustment
UnsecuredNotesFairValueAdjustment
81342000
CY2022Q4 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-23000
CY2021Q4 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-67282000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-26252000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-578084000
CY2022Q4 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-1762000
CY2021Q4 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-712000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-25902000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-544000
CY2022Q4 cgc Gain Loss And Charges Related To Settlement Of Debt
GainLossAndChargesRelatedToSettlementOfDebt
8912000
cgc Gain Loss And Charges Related To Settlement Of Debt
GainLossAndChargesRelatedToSettlementOfDebt
4224000
CY2022Q4 cgc Interest Income
InterestIncome
7048000
CY2021Q4 cgc Interest Income
InterestIncome
1575000
cgc Interest Income
InterestIncome
15922000
cgc Interest Income
InterestIncome
6977000
CY2022Q4 us-gaap Interest Expense
InterestExpense
33288000
CY2021Q4 us-gaap Interest Expense
InterestExpense
26408000
us-gaap Interest Expense
InterestExpense
90660000
us-gaap Interest Expense
InterestExpense
77618000
CY2022Q4 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
2966000
CY2021Q4 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
990000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-8828000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
2902000
CY2022Q4 cgc Gain On Acquisition Disposal Of Consolidated Entity
GainOnAcquisitionDisposalOfConsolidatedEntity
4142000
cgc Gain On Acquisition Disposal Of Consolidated Entity
GainOnAcquisitionDisposalOfConsolidatedEntity
6223000
cgc Gain On Acquisition Disposal Of Consolidated Entity
GainOnAcquisitionDisposalOfConsolidatedEntity
-1653000
CY2022Q4 cgc Other Miscellaneous Non Operating Income Expense Net
OtherMiscellaneousNonOperatingIncomeExpenseNet
-126000
CY2021Q4 cgc Other Miscellaneous Non Operating Income Expense Net
OtherMiscellaneousNonOperatingIncomeExpenseNet
-809000
cgc Other Miscellaneous Non Operating Income Expense Net
OtherMiscellaneousNonOperatingIncomeExpenseNet
-3677000
cgc Other Miscellaneous Non Operating Income Expense Net
OtherMiscellaneousNonOperatingIncomeExpenseNet
-12863000
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-113340000
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
34282000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-406762000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
810769000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-261583000
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-108925000
us-gaap Net Income Loss
NetIncomeLoss
-2566537000
us-gaap Net Income Loss
NetIncomeLoss
272435000
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
486112598
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
393818282
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
453237882
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
390423083
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.70
CY2022Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-261583000
CY2021Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-108925000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2566537000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
272435000
us-gaap Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Redeemable
NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
13100000
cgc Unsecured Notes Removal Fair Value Adjustment
UnsecuredNotesRemovalFairValueAdjustment
81342000
CY2022Q4 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-261583000
CY2021Q4 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-108925000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-2566537000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
177993000
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
486112598
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
393818282
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
453237882
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
390423083
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
486112598
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
393818282
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
453237882
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
410986802
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.66
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2022Q4 cgc Debentures Bear Interest Rate Per Annum
DebenturesBearInterestRatePerAnnum
0.061
CY2019Q2 us-gaap Warrants And Rights Outstanding Maturity Date
WarrantsAndRightsOutstandingMaturityDate
2023-11-01
CY2022Q3 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
101213000
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
140972000
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
122636000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
329191000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
408555000
CY2022Q4 us-gaap Gross Profit
GrossProfit
-2441000
CY2021Q4 us-gaap Gross Profit
GrossProfit
10090000
us-gaap Gross Profit
GrossProfit
-12000
us-gaap Gross Profit
GrossProfit
-33812000
CY2021Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
116835000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
351891000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
355165000
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
6428000
CY2021Q4 us-gaap Share Based Compensation
ShareBasedCompensation
6777000
us-gaap Share Based Compensation
ShareBasedCompensation
21725000
us-gaap Share Based Compensation
ShareBasedCompensation
35856000
CY2022Q4 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
22259000
CY2021Q4 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
36439000
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
1794212000
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
128198000
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-153764000
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-149961000
us-gaap Operating Income Loss
OperatingIncomeLoss
-2167840000
us-gaap Operating Income Loss
OperatingIncomeLoss
-553031000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-100000
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-113340000
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
34282000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-406762000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
810769000
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-267104000
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-115679000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2574602000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
257638000
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
101213000
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
140972000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
329191000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
408555000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
874029000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
942780000

Files In Submission

Name View Source Status
0000950170-23-002383-index-headers.html Edgar Link pending
0000950170-23-002383-index.html Edgar Link pending
0000950170-23-002383.txt Edgar Link pending
0000950170-23-002383-xbrl.zip Edgar Link pending
cgc-20221231.htm Edgar Link pending
cgc-20221231.xsd Edgar Link pending
cgc-ex10_6.htm Edgar Link pending
cgc-ex10_7.htm Edgar Link pending
cgc-ex31_1.htm Edgar Link pending
cgc-ex31_2.htm Edgar Link pending
cgc-ex32_1.htm Edgar Link pending
cgc-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
R115.htm Edgar Link pending
R116.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
cgc-20221231_def.xml Edgar Link unprocessable
cgc-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cgc-20221231_htm.xml Edgar Link completed
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cgc-20221231_lab.xml Edgar Link unprocessable
cgc-20221231_cal.xml Edgar Link unprocessable